MetS-related ED in male rats was prima-rily associated with downregulation of the AMPK/PI3K/eNOS signalling pathway, leading to reduced NO bioavailability and consequent impairment of endothelium-dependent vasorelaxation [21]. The gene discussed is NOS3; the disease is metabolic syndrome.